Prospect Biotech: real-time analysis of cell cultures using light
Project fact sheet
Vertical: Customised health
Project description
The production of advanced therapies, such as CAR-T therapies, is limited by the inefficiencies in the monitoring of cell cultures Furthermore, current technologies do not allow an optimum quality control, which affects scalability and increases costs.
Prospect Biotech offers a solution based on Raman spectroscopy and its enhanced mode with SERS nanoparticles, which function in a complementary manner. Integrated with Artificial Intelligence, these technologies allow the contactless detection of multiple parameters, optimising production in real time. The combination of both improves sensitivity when detecting biomarkers and identifying patterns, which lowers risks and improves productivity in the bioproduction of advanced therapies.
Tagline: Optic technology to optimise the production and effectiveness of the new advanced therapies.
Financing needs: €437,000 first 2.5-3 years (first round) for: Technological development: advanced prototypes, validation in real settings, sensor enhancement and customisation. Operating expenditure: salaries for researchers and business developers, administrative costs. Legal services and patent protection.
Market
The market includes biotech companies, pharmaceuticals, hospitals and research centres. Prospect Biotech targets those firms developing advanced therapies, such as CAR-T cell therapies, bioproduction of viral vectors, cultured meat, along with research laboratories and universities.
Technology tags
Business model
Project needs
Promoted by
Are you interested in high-tech projects capable of generating greater market impact?
Fill in this form and we will contact you if you want to take part in this initiative – either by contributing technology assets or if you are a talent promoter capable of turning them into business projects.
Related news
Makby: 3D bioprinting software for regenerative medicine
Basque Tek Ventures is backing this initiative that will revolutionise the field of artificial biological tissues.
Konbus+: Controlled temperature and high velocity thermal spray systems
The initiative, coming under Basque Tek Ventures, provides high value-added coatings in extreme conditions in a cost-effective manner.
K-ALMA: Generative AI for reliable software tests
Basque Tek Ventures is backing this project that automates the code validations by reducing their high certification cost.
INTELLIWELD: assessment of weld quality
Basque Tek Ventures supports this initiative offering an integrated system to analyse and control process and product in welding systems.
FATRIXGEL: universal biomaterial for 3D cell cultures
The project, coming under Basque Tek Ventures, will revolutionise the generation of tissues to be used to research pharmaceutical and biotechnological therapies.
CRIOKEEP: device for the cryogenic storage, transport and dosing of therapeutic products
Basque Tek Ventures is backing this solution to improve the effectiveness of advanced medicine therapies by lowering risks and costs.
BATTBELT: mechanical management of batteries to improve their performance
The project, which is part of the Basque Tek Ventures initiative, helps to extend the life and energy density of lithium-ion batteries.
ORBIK: cybersecurity solutions for equipment with embedded electronics
Certification of technology products by means of assessing, detecting and monitoring their security vulnerabilities is the basis of this project hosted by the Basque Tek Ventures initiative.
OPTIDEL Biosystems: low liquefiable polyphenol solubilisation
The project, backed by the Basque Tek Ventures initiative, offers cosmetic-healthcare solutions to formulate more efficient topical products at a low cost.
NEWRO: stroke neurorehabilitation using robotic exoskeleton
The project, part of the Basque Tek Ventures initiative, will lead to therapies based on the hybrid brain-machine interface to recover after any degree of stroke.